MPCC

Thanks to David Einstein, MD, from Beth Israel Deaconess Medical Center, for discussing “Into the Unknown: How Do We Study Prostate Cancer Treatments?” For every exciting new therapy, there is a long road of research along which many other [...]

Thanks to Christina Dieli-Conwright, PhD, MPH, Dana-Farber Cancer Institute for discussing “Exercise as Medicine for Prostate Cancer Survivorship.” Persons at risk and diagnosed with prostate cancer are a vulnerable population in need of non-pharmacologic interventions to improve health outcomes. [...]

Thanks to Adam Feldman, MD, MPH, for discussing “Prostate Cancer Detection: Past, Present and Future.” Dr. Feldman is a urologic oncologist at the Massachusetts General Hospital Department of Urology. Director of the Combined Harvard Fellowship Program in Urologic Oncology [...]

Thanks to Dr. Marianne Brandon, clinical psychologist and diplomat in sex therapy, for this interview on “Sex and Intimacy after Prostate Cancer,” in which she discusses this topic in the broader context of intimacy and sexuality. [...]

Thanks to Dr. Mark Pomerantz, a medical oncologist at the Dana-Farber Cancer Institute, for today’s interview. In this podcast he discusses “Genetics and Prostate Cancer” – highlighting recent discoveries and changes in the field of genetics and how they [...]

Thanks to Lorelei Mucci, ScD, MPH, for this interview discussing “The State of Evidence Behind Lifestyle and Diet for Prostate Cancer Patients.” Dr. Mucci is the Director of the Cancer Epidemiology and Cancer Prevention Program in the Department of [...]

Today’s podcast features Dr. Jairam Eswara from St. Elizabeth’s Medical Center in Boston discussing “Signs, Symptoms and Treatment Options for Erectile Dysfunction and Male Stress Urinary Incontinence Post Prostate Cancer.” Dr. Eswara will be discussing this topic in more [...]

Today’s podcast features a compilation of interviews held at the 2019 Jack Colbert Memorial Award Reception at the Harvard Club in Boston in September as part of Prostate Cancer Awareness Month. Participants include the 2019 recipient, Clare Tempany, MD, [...]

Today’s podcast features a discussion on health value assessments, drug costs, and the potential implications for men diagnosed with prostate cancer. Interviewed on this topic are Robert Popovian, Doctor in Pharmacy and Vice President, US Government Relations at Pfizer [...]

Today’s podcast features interviews with several attendees and presenters at the 2019 Massachusetts Prostate Cancer Symposium on May 10. First up is Mark Anthony Hunter of The Goddard School and a member of the MPCC board. Mark’s father had prostate cancer and he [...]